The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
AusPAR: Secukinumab
Australian Public Assessment Report
Device/Product Name
Cosentyx
Active ingredients
Secukinumab
AusPAR Date
Published
Submission Number
PM-2019-04601-1-3
Submission Type
Extension of indications
Decision
Approved